Two novel GALNT3 mutations in familial tumoral calcinosis

Holly J. Garringer, Seyed Mohammad Javad Mortazavi, Fatemehsadat Esteghamat, Mahdi Malekpour, Harika Boztepe, Refik Tanakol, Siobhan I. Davis, Kenneth E. White

Research output: Contribution to journalArticle

31 Scopus citations


Familial tumoral calcinosis (TC) is characterized by elevated serum phosphate concentrations, normal or elevated 1,25(OH)2 vitamin D, as well as periarticular and vascular calcifications. Recessive mutations in the mucin-like glycosyltransferase GalNAc transferase-3 (GALNT3) and the phosphaturic hormone fibroblast growth factor-23 (FGF23) have been shown to result in TC. In the present study, mutational analyses were performed on two patients with TC to determine the molecular basis of their diseases. Analysis of the first patient revealed a novel, homozygous base insertion (1102_1103insT) in GALNT3 exon 5 that results in a frameshift and premature stop codon (E375X). The second patient had a novel homozygous transition (1460 g>a) in GALNT3 exon 7, which caused a nonsense mutation (W487X). Both mutations are predicted to markedly truncate the mature GALNT3 protein product. Although the patients carry GALNT3 mutations, these individuals presented with low-normal serum concentrations of intact biologically active FGF23 and high levels of C-terminal FGF23. In order to discern a possible relationship between GALNT3 and FGF23 in TC, a comprehensive assessment of the reported TC mutations was also performed. In summary, we have detected novel GALNT3 mutations that result in familial TC, and show that disturbed serum FGF23 concentrations are present in our TC cases as well as in previously reported cases. These studies expand our current genetic understanding of familial TC, and support a pathophysiological association between GALNT3 and FGF23.

Original languageEnglish (US)
Pages (from-to)2390-2396
Number of pages7
JournalAmerican Journal of Medical Genetics, Part A
Issue number20
StatePublished - Oct 15 2007


  • FGF-23
  • FGF23
  • Fibroblast growth factor-23
  • GalNAc-T3
  • Hyperphosphatemia
  • Phosphate
  • TC

ASJC Scopus subject areas

  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Two novel GALNT3 mutations in familial tumoral calcinosis'. Together they form a unique fingerprint.

  • Cite this

    Garringer, H. J., Mortazavi, S. M. J., Esteghamat, F., Malekpour, M., Boztepe, H., Tanakol, R., Davis, S. I., & White, K. E. (2007). Two novel GALNT3 mutations in familial tumoral calcinosis. American Journal of Medical Genetics, Part A, 143(20), 2390-2396.